Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2010 3
2011 1
2012 3
2013 3
2014 5
2015 3
2016 1
2017 4
2018 6
2019 9
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Soft Tissue and Uterine Leiomyosarcoma.
George S, Serrano C, Hensley ML, Ray-Coquard I. George S, et al. Among authors: Serrano C. J Clin Oncol. 2018 Jan 10;36(2):144-150. doi: 10.1200/JCO.2017.75.9845. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220301 Free PMC article. Review.
GEIS guidelines for gastrointestinal sarcomas (GIST).
Poveda A, García Del Muro X, López-Guerrero JA, Cubedo R, Martínez V, Romero I, Serrano C, Valverde C, Martín-Broto J; GEIS (Grupo Español de Investigación en Sarcomas/Spanish Group for Sarcoma Research). Poveda A, et al. Among authors: Serrano C. Cancer Treat Rev. 2017 Apr;55:107-119. doi: 10.1016/j.ctrv.2016.11.011. Epub 2017 Mar 2. Cancer Treat Rev. 2017. PMID: 28351781 Free article. Review.
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors.
Serrano C, Leal A, Kuang Y, Morgan JA, Barysauskas CM, Phallen J, Triplett O, Mariño-Enríquez A, Wagner AJ, Demetri GD, Velculescu VE, Paweletz CP, Fletcher JA, George S. Serrano C, et al. Clin Cancer Res. 2019 Dec 15;25(24):7287-7293. doi: 10.1158/1078-0432.CCR-19-2150. Epub 2019 Aug 30. Clin Cancer Res. 2019. PMID: 31471313
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors.
Ravegnini G, Sammarini G, Serrano C, Nannini M, Pantaleo MA, Hrelia P, Angelini S. Ravegnini G, et al. Among authors: Serrano C. Ther Adv Med Oncol. 2019 Mar 1;11:1758835919831902. doi: 10.1177/1758835919831902. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30854029 Free PMC article. Review.
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Serrano C, Mariño-Enríquez A, Tao DL, Ketzer J, Eilers G, Zhu M, Yu C, Mannan AM, Rubin BP, Demetri GD, Raut CP, Presnell A, McKinley A, Heinrich MC, Czaplinski JT, Sicinska E, Bauer S, George S, Fletcher JA. Serrano C, et al. Br J Cancer. 2019 Mar;120(6):612-620. doi: 10.1038/s41416-019-0389-6. Epub 2019 Feb 22. Br J Cancer. 2019. PMID: 30792533 Free PMC article.
Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.
Serrano-Candelas E, Ainsua-Enrich E, Navinés-Ferrer A, Rodrigues P, García-Valverde A, Bazzocco S, Macaya I, Arribas J, Serrano C, Sayós J, Arango D, Martin M. Serrano-Candelas E, et al. Among authors: Serrano C. Mol Oncol. 2018 Aug;12(8):1383-1397. doi: 10.1002/1878-0261.12332. Epub 2018 Jun 30. Mol Oncol. 2018. PMID: 29885053 Free PMC article.
The rs17084733 variant in the KIT 3' UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility.
Ravegnini G, Serrano C, Simeon V, Sammarini G, Nannini M, Roversi E, Urbini M, Ferrè F, Ricci R, Tarantino G, Pantaleo MA, Hrelia P, Angelini S. Ravegnini G, et al. Among authors: Serrano C. Epigenetics. 2019 Jun;14(6):545-557. doi: 10.1080/15592294.2019.1595997. Epub 2019 Apr 13. Epigenetics. 2019. PMID: 30983504 Free PMC article.
Leiomyosarcoma.
Serrano C, George S. Serrano C, et al. Hematol Oncol Clin North Am. 2013 Oct;27(5):957-74. doi: 10.1016/j.hoc.2013.07.002. Epub 2013 Aug 26. Hematol Oncol Clin North Am. 2013. PMID: 24093170 Review.
41 results
Jump to page
Feedback